Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
26 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
PRE 14A
Preliminary proxy
12 Apr 24
S-3
Shelf registration
20 Mar 24
10-K
2023 FY
Annual report
20 Mar 24
8-K
HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress
20 Mar 24
8-K
Departure of Directors or Certain Officers
18 Jan 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Amendments to Articles of Incorporation or Bylaws
8 Dec 23
10-Q
2023 Q3
Quarterly report
9 Nov 23
8-K
HilleVax Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
9 Nov 23
8-K
HilleVax Announces Proposed Public Offering of Common Stock
20 Sep 23
424B5
Prospectus supplement for primary offering
20 Sep 23
424B5
Prospectus supplement for primary offering
19 Sep 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
HilleVax Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
14 Aug 23
8-K
Entry into a Material Definitive Agreement
22 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
13 Jun 23
EFFECT
Notice of effectiveness
22 May 23
CORRESP
Correspondence with SEC
17 May 23
UPLOAD
Letter from SEC
16 May 23
S-3
Shelf registration
12 May 23
10-Q
2023 Q1
Quarterly report
12 May 23
8-K
HilleVax Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
12 May 23
DEFA14A
Additional proxy soliciting materials
10 May 23
8-K
Departure of Directors or Certain Officers
9 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
8-K
Other Events
25 Apr 23
8-K
Departure of Directors or Certain Officers
18 Apr 23
10-K
2022 FY
Annual report
17 Mar 23
8-K
HilleVax Reports Full Year 2022 Financial Results and Highlights Recent Company Progress
17 Mar 23
8-K
Departure of Directors or Certain Officers
9 Jan 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
8-K
HilleVax Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress
10 Nov 22
8-K
Other Events
31 Aug 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
8-K
HilleVax Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
10 Aug 22
Latest ownership filings
4
James N Topper
8 Apr 24
4
Aditya Kohli
5 Apr 24
4
Sean McLoughlin
1 Apr 24
4
Aditya Kohli
20 Mar 24
144
Notice of proposed sale of securities
20 Mar 24
4
Aditya Kohli
8 Mar 24
4
Aditya Kohli
22 Feb 24
SC 13G/A
Lightspeed Venture Partners Select IV, L.P.
14 Feb 24
SC 13G/A
RA CAPITAL MANAGEMENT, L.P.
14 Feb 24
4
Aditya Kohli
14 Feb 24
SC 13G/A
Deep Track Capital, LP
14 Feb 24
4
Aditya Kohli
12 Feb 24
4
Shane Maltbie
12 Feb 24
4
ROBERT HERSHBERG
12 Feb 24
4
Astrid Borkowski
12 Feb 24
SC 13G/A
Flynn James E
12 Feb 24
SC 13G/A
Carlyle Group Inc.
12 Feb 24
144
Notice of proposed sale of securities
12 Feb 24
4
Sean McLoughlin
2 Feb 24
3
Sean McLoughlin
26 Jan 24
144
Notice of proposed sale of securities
22 Jan 24
4
Astrid Borkowski
18 Dec 23
144
Notice of proposed sale of securities
18 Dec 23
144
Notice of proposed sale of securities
5 Dec 23
144
Notice of proposed sale of securities
5 Dec 23
4
Astrid Borkowski
5 Dec 23
144
Notice of proposed sale of securities
27 Nov 23
144
Notice of proposed sale of securities
27 Nov 23
4
Astrid Borkowski
20 Nov 23
4
Astrid Borkowski
13 Nov 23
SC 13G
Deep Track Capital, LP
29 Sep 23
SC 13D/A
Frazier Life Sciences Public Fund, L.P.
27 Sep 23
4
Astrid Borkowski
23 Jun 23
144
Notice of proposed sale of securities
20 Jun 23
4
Shelley Chu
9 Jun 23
4
Nanette Cocero
9 Jun 23
4
Julie L. Gerberding
9 Jun 23
4
Jaime Sepulveda
9 Jun 23
4
JERYL L HILLEMAN
9 Jun 23
4
Patrick J Heron
9 Jun 23